Gautier Chene1, Anne Cayre2, Ines Raoelfils2, Nicole Lagarde2, Jacques Dauplat3, Frederique Penault-Llorca2. 1. Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, France; EA ERTICa, Université d'Auvergne, Clermont-Ferrand, France; Department of Gynecology, CHU Lyon, Lyon, France. Electronic address: chenegautier@yahoo.fr. 2. Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, France; EA ERTICa, Université d'Auvergne, Clermont-Ferrand, France. 3. Department of Surgery, Centre Jean Perrin, Clermont-Ferrand, France.
Abstract
OBJECTIVE: Histopathological examination of material from prophylactic salpingo-oophorectomies performed in patients at genetic risk of ovarian cancer can reveal abnormalities interpreted as possible pre-cancerous "ovarian dysplasia" and tubal precursors lesions. We sought to study the morphological features and immunohistochemical expression patterns of neoplasia-associated markers in prophylactically removed ovaries and fallopian tubes (pBSO) in comparison with a group of serous tubal intraepithelial carcinoma (STIC) and non-cancerous controls. STUDY DESIGN: Morphological features and immunohistochemical expression patterns of Ki-67 (for proliferation biomarker), p53 (key pathway of mullerian serous tumorogenesis), Bcl2 (anti-apoptotic), γH2AX (a double-strand breaks marker) and ALDH1 (a stem cell marker significantly associated with early-stage ovarian cancer) were blindly evaluated by two pathologists in 111 pBSO, 12 STICs and 116 non-cancerous salpingo-oophorectomies (control group) (nBSO). RESULTS: Morphological ovarian and tubal dysplasia scores were significantly higher in the pBSO than in controls (respectively, 8.8 vs 3.12, p<0.0001, for ovaries and 6.54 vs 1.58, p<0.0001 for tubes). Increased γH2AX expression was observed in the pBSO and STICs compared with the controls whereas expression patterns of Ki67, p53 and bcl2 were low to moderate in the pBSO group. STICs overexpressed Ki67 and p53 while bcl2 expression was low; Interestingly, ALDH1 expression was low in non dysplastic epithelium, high in dysplasia and constantly low in STICs. CONCLUSION: The morphological and immunohistochemical profile of tubo-ovarian dysplasia and STICs might be consistent with progression toward neoplastic transformation in the Serous Carcinogenesis Sequence. These changes may be pre-malignant and could represent an important phase in early neoplasia. ALDH1 activation in pBSO samples and its extinction in STICs should be considered as a target for prevention.
OBJECTIVE: Histopathological examination of material from prophylactic salpingo-oophorectomies performed in patients at genetic risk of ovarian cancer can reveal abnormalities interpreted as possible pre-cancerous "ovarian dysplasia" and tubal precursors lesions. We sought to study the morphological features and immunohistochemical expression patterns of neoplasia-associated markers in prophylactically removed ovaries and fallopian tubes (pBSO) in comparison with a group of serous tubal intraepithelial carcinoma (STIC) and non-cancerous controls. STUDY DESIGN: Morphological features and immunohistochemical expression patterns of Ki-67 (for proliferation biomarker), p53 (key pathway of mullerian serous tumorogenesis), Bcl2 (anti-apoptotic), γH2AX (a double-strand breaks marker) and ALDH1 (a stem cell marker significantly associated with early-stage ovarian cancer) were blindly evaluated by two pathologists in 111 pBSO, 12 STICs and 116 non-cancerous salpingo-oophorectomies (control group) (nBSO). RESULTS: Morphological ovarian and tubal dysplasia scores were significantly higher in the pBSO than in controls (respectively, 8.8 vs 3.12, p<0.0001, for ovaries and 6.54 vs 1.58, p<0.0001 for tubes). Increased γH2AX expression was observed in the pBSO and STICs compared with the controls whereas expression patterns of Ki67, p53 and bcl2 were low to moderate in the pBSO group. STICs overexpressed Ki67 and p53 while bcl2 expression was low; Interestingly, ALDH1 expression was low in non dysplastic epithelium, high in dysplasia and constantly low in STICs. CONCLUSION: The morphological and immunohistochemical profile of tubo-ovarian dysplasia and STICs might be consistent with progression toward neoplastic transformation in the Serous Carcinogenesis Sequence. These changes may be pre-malignant and could represent an important phase in early neoplasia. ALDH1 activation in pBSO samples and its extinction in STICs should be considered as a target for prevention.
Authors: Gustavo C Rodriguez; James Kauderer; Jessica Hunn; Larry G Thaete; William G Watkin; Samantha Russell; Michael Yozwiak; Jack Basil; Jean Hurteau; Shashikant Lele; Susan C Modesitt; Oliver Zivanovic; Hao Helen Zhang; Peter H Bartels; David S Alberts Journal: Cancer Prev Res (Phila) Date: 2019-04-23
Authors: Dmitriy W Gutkin; Michael R Shurin; Mounia Alaoui El Azher; Galina V Shurin; Liudmila Velikokhatnaya; Denise Prosser; Namhee Shin; Francesmary Modugno; Paul Stemmer; Esther Elishaev; Anna Lokshin Journal: Cancer Biomark Date: 2019 Impact factor: 4.388
Authors: Caroline S Dillenburg; Marco A T Martins; Luciana O Almeida; Luise Meurer; Cristiane H Squarize; Manoela D Martins; Rogerio M Castilho Journal: Medicine (Baltimore) Date: 2015-07 Impact factor: 1.889
Authors: G Chene; V Ouellet; K Rahimi; V Barres; L Meunier; M De Ladurantaye; D Provencher; A M Mes-Masson Journal: Biomed Res Int Date: 2015-10-04 Impact factor: 3.411